¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"minimal blocking concentration"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
minimal change disease
¹Ì¼¼º¯Èº´
minimal current gradient
ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
minimal erythema dose
ÃÖ¼ÒÈ«¹Ý¼±·®
minimal identifiable odor
ÃÖ¼ÒÀνij¿»õ, ÃÖ¼ÒºÐÇØÃë°¢
minimal infecting dose
ÃÖ¼Ò°¨¿°¿ë·®
minimal lethal dose
1. ÃÖ¼ÒÄ¡»ç·® 2. ÃÖ¼ÒÄ¡»ç¼±·®
minimal stimulus
ÃÖ¼ÒÀÚ±Ø
minimal tension line
ÃÖ¼ÒÀå·Â¼±
minimal visible angle
Ãּҽð¢
minimal volition period
ÃÖ¼Ò¼öÃà±â
blood concentration
Ç÷Áß³óµµ
concentration
1. ³óÃà 2. ³óµµ 3. ÁýÁß
concentration effect
³óµµÈ¿°ú
concentration-response curve
³óµµ¹ÝÀÀ°î¼±
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
minimal brain dysfunction
°æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
minimal change disease
ÃÖ¼Òº¯ÈÄáÆÏº´Áõ
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
minimal erytherma dose
ÃÖ¼ÒÈ«¹Ý¼±·®
minimal lethal dose
ÃÖ¼ÒÄ¡»ç·®, ÃÖ¼ÒÄ¡»ç¼±·®
minimal enhancement
¹Ì¹ÌÇÑÁ¶¿µÁõ°, °æµµÁ¶¿µÁõ°
minimal current gradient
ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
minimal tension line
ÃÖ¼ÒÀå·Â¼±
minimal stimulus
ÃÖ¼ÒÀÚ±Ø
minimal angle resolution
ÃÖ¼Ò°¢ºÐÇØ´É
minimal daily requirement
ÃÖ¼Ò¿µ¾çÇʿ䷮, ÃÖ¼ÒÀÏÀϿ䱸·®
minimal identifiable odor
ÃÖ¼ÒºÐÇØÃë°¢, ÃÖ¼ÒÀνij¿»õ
minimal nerve excitability test
ÃּҽŰæÀڱذ˻ç
minimal stimulating test
¹Ì¾àÁÖÀÔÀڱؽÃÇè
minimal volition period
ÃÖ¼Ò¼öÃà±â
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
MAC=> maximum allowable concentration
ÃÖ´ëÇã¿ë³óµµ.
MAC=ÊÝmaximum allowable concentration
ÃÖ´ëÇã¿ë³óµµ.
MCHC => mean cell hemogiooln concentration
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
PCFIA => particle concentration fluorescence immunoassay
ÀÔÀÚ³óÃàÇü±¤¸é¿ªÃøÁ¤(¹ý)
area under the concentration-time curve : AUC
Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
fractional concentration
ºÐȹ³óµµ(ÝÂüñÒØÓø).
fractional concentration
ºÐȹ³óµµ.
hemoglobin content/concentration
Ç÷»ö¼ÒÇÔ·®/³óµµ
hydrogen ion concentration
¼ö¼ÒÀ̿³óµµ.
inhibitory concentration, minimum (MIC)
¾ïÁ¦ÃÖ¼Ò³óµµ
plasma concentration
Ç÷Àå³óµµ.
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
blocking of thought
»ç°íÀÇ ¸·Èû
blocking test
Â÷´Ü½ÃÇè(ó´Ó¨ãËúÐ).
calcium channel blocker ; calcium channel blocking drug
Ä®½·Åë·ÎºÀ¼â¾à ¹°<Á¦>, Ä®½·Åë·Î Â÷´Ü¾à¹°<Á¦>.
calcium channel blocker ; calcium channel blocking drug
Ä®½·Åë·ÎºÀ¼â¾à¹°<Á¦>, Ä®½·Åë·ÎÂ÷´Ü¾à¹°<Á¦>.
cholinergic blocking agent
Äݸ°¼ºÂ÷´ÜÁ¦
cholinergic blocking agent
Ç×Äݸ°¼º¾à(ù÷¡å·), Äݸ°¼º Â÷´Ü<ºÀ¼â>Á¦.
competitive blocking agent
°æÀZ(Ìæî³àõ) Â÷´ÜÁ¦(ó´Ó¨ð¥).
competitive blocking agent
°æÇÕ¼º Â÷´ÜÁ¦.
depolarizing neuromuscular blocking drug
Å»ºÐ±Ø¼º ½Å°æ±ÙºÀ¼â¾à¹°.
ganglionic blocking action
½Å°æÀýÂ÷´ÜÀÛ¿ë.
ganglionic blocking agent
½Å°æÀýÂ÷´ÜÁ¦.
genetic blocking
À¯ÀüÀû Â÷´Ü(ë¶îîîÜó´Ó¨).
genetic blocking
À¯ÀüÀû Â÷´Ü.
neuromuscular blocking agent
½Å°æ±ÙÂ÷´Ü<ºÀ¼â>Á¦(¾à).
neuromuscular blocking agent
½Å°æ±ÙÂ÷´ÜÁ¦, ½Å°æ±ÙÂ÷´Ü¾à(~ó´Ó¨å·).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½